DJIA 17,387.21 -291.49 -1.65%
NASDAQ 4,681.50 -90.27 -1.89%
S&P 500 2,029.55 -27.54 -1.34%
market minute promo

Roche Holding Ltd. (ADR) (NASDAQOTH: RHHBY)

35.70 0.22 (0.63%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RHHBY $35.70 0.63%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $35.64
Previous Close $35.48
Daily Range $35.42 - $35.81
52-Week Range $33.23 - $38.71
Market Cap $200.7B
P/E Ratio 0.00
Dividend (Yield) $0.00 (2.6%)
Volume 984,435
Average Daily Volume 2,238,147
Current FY EPS $2.00





Roche Holding Ltd. (ADR) (RHHBY) Description


News & Commentary Rss Feed

This Popular Beverage Could Be Responsible For a 20% Reduction in Melanoma Risk

The good news: this beverage reduced the risk of an aggressive form of skin cancer by 20% in a very large study. The better news: 83% of you are already consuming this beverage on a daily basis!

These 3 Pharmaceutical Companies Control Roughly Half of All Cancer Drug Sales

Global cancer drug sales totaled $91 billion in 2013 and are expected to breach $100 billion in sales sooner than you think. Yet, three big pharmaceutical companies currently control about half of all cancer drug sales.

Here's Why This Year's Flu Vaccine Isn't Working

Have you ever wondered why the effectiveness of the flu vaccine is so erratic from one year to the next? Here's the answer.

State of the Union Address Investing Idea: Precision Medicine

There are plenty of companies developing precision medicine drugs already, and investors would be wise to watch key players.

3 Warning Signs You've Invested in a Dangerous Biotech Stock

Three Motley Fool analysts help investors spot biotech stock warning signals.

Will Organovo Holdings Inc. be Bought Out in 2015?

It could happen, but here's why long-term investors should ignore this noise anyway.

Can You Guess Which Big Pharma Has a More Robust Pipeline Than Pfizer, Inc.?

Pfizer's pipeline currently features 86 clinical studies and/or registrations. That's an incredible figure that demonstrates Pfizer's commitment to R&D. But, it's also not the most robust pipeline in the pharmaceutical sector. Can you guess which big pharma company has an even larger pipeline than Pfizer?

Why Shares of Foundation Medicine, Inc. Skyrocketed Today

Shares of cancer diagnostic maker Foundation Medicine more than doubled Monday morning. Here's why.

Why ImmunoGen, Inc. Stock Was Decimated in December

ImmunoGen was the worst biotech stock in December after it and its partner Roche released disappointed study data. Find out whether the mauling was merited or if ImmunoGen shares could be a bargain here.

What's the Next Stop for Inovio: $5 or $15?

With its shares up 500% over the past two years, is Inovio poised for more upside or a 50% haircut?

See More RHHBY News...

RHHBY's Top Competitors

RHHBY $35.70 (0.63%)
Current stock: RHHBY
GSK $45.16 (-0.07%)
Current stock: GSK
JNJ $102.09 (-0.17%)
Current stock: JNJ
PFE $32.60 (-0.61%)
Current stock: PFE